Learn why the body ages, when disease originates, and how top clinicians are changing their patients lives by treating the body
Unlike standard oral supplements, our B12 treatments are administered by healthcare professionals using methods that maximize absorption and effectiveness
P.BernasconiF.MutiranguraA.LedbetterD
Sources Novo Nordisk NDA filing for CagriSema, December 18, 2025 American Diabetes Association REDEFINE-1 and REDEFINE-2 results, ADA 2026 Scientific Sessions HCPLive REDEFINE-1 Phase 3 safety and efficacy data Clinical Trials Arena REDEFINE-4: CagriSema vs tirzepatide head-to-head, February 2026 Life Science Daily News CagriSema FDA review timeline and NDA update, July 2026 PharmExec REDEFINE-1 results: CagriSema falls short of 25% weight loss target Drugs.com CagriSema FDA approval status history New England Journal of Medicine REDEFINE-1 full publication (presented at ADA 2026) Novo Nordisk REIMAGINE Phase 3 diabetes trial results, ADA 2026 and The Lancet FDA Wegovy (semaglutide) prescribing information, 2025 Related reading on Heally: What is Wegovy HD
Aug 2007;50(8):1211-1214
Chondroprotective effects of bone marrow mesenchymal stem cell-derived exosomes in osteoarthritis
